FDA Investigator Kent C Faul

Kent C Faul has conducted inspections on 53 sites in 17 countries as of 17 Apr 2007. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
53
Last Inspection Date:
17 Apr 2007
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
China, Switzerland, Taiwan, France, Italy, India, United States of America, Germany, Israel, United Kingdom of Great Britain and Northern Ireland, South Africa, Poland, Ireland, Mexico, Netherlands, Norway, Denmark
FDA Investigators that have inspected at least one site in common with Kent C Faul:
Ademola O Daramola, Alan P Kurtzberg, Alberto A Viciedo, Alicia M Mozzachio, Anastasia G Lolas, Angela E Glenn, Anissa M Vargas, Anjali Shukla, PhD, Ann Marie Montemurro, Anthony A Charity, Anthony J Lagreca, Arnold Seo, PhD, Arsen Karapetyan, Ashar P Parikh, Azza Talaat, Barbara J Rincon, Barbara J White, Barbara M Frazier, Betty Kay Baxter, Bill Tacket, Jr, Blondell W Johnson, Brandon C Heitmeier, Bruce H Mccullough, Bryce A Hammer, Carl A Anderson, Caroline H Le, CDR Ileana Barreto Pettit, Charanjeet Jassal, Charles D Brown, Charles I Ann, Charles M Edwards, Cheryl A Clausen, Christopher M Jenner, Concepcion Cruz, Jr, Cynthia J Lee, MS, Cynthia Jim, CSO, Cynthia M Goudeau, Darren S Brown, David A Oluwo, David M Beltran, Debra I Love, Dennis Cantellops Paite, Derek S Smith, PhD, Devaughn Edwards, Don H Bark, PhD, Donald L Lech, Dr. Mark J Seaton, PhD, Dr. Robert C Horan, MD, Dr. Zhou Chen (nmi), MD PhD, Edmund F Mrak, Jr, Edwin Martinez, Edwin Melendez, Eric L Dong, BS, Erika V Butler, Frank L Cordova, Freddy Ortiz Colon, Frederick F Razzaghi, Frederick L Fricke, George A Prager, Gerardo Z Vazquez, German Rivera, Ginger M Sykes, Grace E Mcnally, Gwyn G Dickinson, Hamet M Toure, PharmD MPH, Hanna L Potter, Haroon Vohra (NMI), Helen B Ricalde, Heriberto Negron Rivera, Hugh M Mcclure, II, Isabel Y Espinosa, James C Maclaughlin, James P Mcreavey, James P Stumpff, Jamie L Dion, Javier O Vega, Jeffery A Hangartner, Jeffrey D Meng, Jennifer C Adams, Jessica Chery, Jessica L Pressley, Joanne M Schlossin, Joel D Hustedt, Jogy George, Jonah S Ufferfilge, Jonathan G Matrisciano, Joo Jin, Jose Acruz Gonzalez, José E Meléndez, Jose R Hernandez, Julie D Bringger, Justin R Carr, Kalavati Suvarna, PhD, Karen A Wolnik, Karen G Hirshfield, Karen Takahashi, Karen Wolnik, Karyn M Campbell, Katherine E Jacobitz, Katherine Szestypalow, Kathleen R Jones, PhD, Keith S Ehrlich, Kevin D Kallander, Kham Phommachanh, Kim Lthomas Cruse, Kimberley A Hoefen, Kula N Jha, Larry K Austin, Laurie Nelson, LCDR Debra Emerson, Leonard H Lavi, Li Hongpaul Yeh, PhD, Linda M Cheny, Lisa Shin, Lloyd D Payne, Lori B Wikstrom, Lori Wikstrom, Lourdes Valentin Aponte, Luis A Carrion, Luis A Dasta, Luis Mburgos Medero, Madushini Dharmasena, PhD, Margaret M Annes, Marie F Morin, Mary E Storch, Matthew B Casale, Matthew J Hansen, Matthew R Dionne, Maxwell Van Tassell, PhD, Mei Chiung Huang (Jo), Meisha R Sampson, Melba Trivera Clavell, Michael A Charles, Michael J Kuchta, Michael Kuchta, Michael L Casner, Michael R Goga, Michael S Araneta, Michele L Forster, PhD, Michele L Obert, Michele Perry Williams, Mihaly S Ligmond, Minh D Phan, Mra Davism, Mra Mcculloughj, Mra Munizn, Mra Narulaa, Muralidhara B Gavini, PhD, Nancy G Schmidt, Nasir Ali, PhD, Nathan M Jornod, Nayan J Patel, Nicole E Knowlton, Omotunde O Osunsanmi, Paraluman S Leonin, Parul M Patel, Patricia A Brown, Patricia A Cortez, Patricia Brown, Patricia F Hughes, PhD, Patricia H Dlugosz, Patsy J Domingo, Patty P Kaewussdangkul, Paul L Bellamy, Paul L Figarole, Jr, Peter E Baker, Peter R Lenahan, Phillip Angart, PhD, Prabhu P Raju, Pratik S Upadhyay, DDC, Rafael E Arroyo, Rafael Nevarez Nieves, Ralph H Vocque, Ramesh Potla, PhD, Randy L Self, Raquel Gonzalez Rivera, Raymond T Oji, Rebecca H Lee, Rebecca Parrilla, Rebecca Rodriguez, Regina T Brown, Richard E Needham, Richard H Penta, Ricki A Chase, Robert C Coleman, Robert J Ham, Robert J Martin, Robert M Barbosa, Robert Sharpnack, Rochelle L Cross, Rumany C Penn, PharmD, Ruth A Williams, Saleem A Akhtar, Samantha J Bradley, Sandra A Hughes, Sangeeta M Khurana, PhD, Sarah E Mcmullen, Scott T Ballard, Seneca D Toms, Sharon K Thoma, PharmD, Shawn R Gould, Shirley J Berryman, Sidney B Priesmeyer, Sixto M Mercado Rios, Sony Mathews, Stefanie R Cook, Stephen D Brown, Stephen T Hansen, Steven D Kehoe, Steven M Weinman, Susan F Laska, MS, Susan L Young, Susan M Jackson, Susan W Ting, Susanna E Ford, Suzanne N Vallez, Suzanne Vallez, Syed N Ali, Sylvia A Craven, Taichun Qin, PhD, Tajah L Blackburn, Tamil Arasu, PhD, Teena H Aiken, Tenzin Jangchup, Terri L Dodds, Thai T Duong, Theressa B Smith, Thomas A Peter, Thomas E Friel, Thomas J Arista, Tiffani D Wilson, Timothy T Kapsala, Tracey L Harris, Travis S Bradley, Trinidad D Barreras, Veronica Fuentes, MS, Vlada Matusovsky, Walden H Lee, Wayne E Seifert, Wen Ning Chan (Sally), William J Leonard, Xiaokuang Lai, PhD, Xikui Chen (nmi), PhD, Yanming An, PhD, Yasamin Ameri, Yumi J Hiramine, Yvette I Henry, Yvette I Johnson, Yvins Dezan, Yvonne E Lozano, Zachary A Bogorad, Zachary L Miller, Zachary L Stamm, Zhong Li, PhD

Kent C Faul's Documents

Publish Date Document Type Title
November, 2003 EIR SHANGHAI ZHONGXI SUNVE PHARMACEUTICAL CO., LTD. - EIR, 2003-11-13
May, 2001 EIR Johnson Matthey Pharmaceuticals Materials - EIR, 2001-06-11
November, 2003 FDA 483 SHANGHAI ZHONGXI SUNVE PHARMACEUTICAL CO., LTD. - Form 483, 2003-11-13
October, 2002 EIR Shanghai Fourth Pharmaceuticals, Ltd. - EIR, 2002-10-31
October, 2002 EIR Sichuan Long March Pharmaceutical Co. Ltd. - EIR, 2002-10-25
September, 2003 EIR Abic Ltd. - EIR, 2003-09-10
November, 2003 EIR Wuxi Kaili Pharmaceutical Company LTD. - EIR, 2003-12-08
October, 2002 FDA 483 Response Sichuan Long March Pharmaceutical Co. Ltd. - Form 483R, 2002-11-20
October, 2000 EIR Sandoz Incorporated - EIR, 2000-10-11
March, 2007 FDA 483 Dr Reddy's Laboratories Limited - Form 483, 2007-03-09
October, 2002 FDA 483 Nanjing Pharmaceutical Factory Co., Ltd. - Form 483, 2002-10-17
April, 2007 EIR Cody Laboratories, Inc. - EIR, 2007-04-27
October, 2002 EIR Nanjing Pharmaceutical Factory Co., Ltd. - EIR, 2002-10-17
October, 2002 FDA 483 Response Shanghai Fourth Pharmaceuticals, Ltd. - Form 483R, 2002-12-06
March, 2007 FDA 483 DR REDDY'S LABORATORIES LIMITED - Form 483, 2007-03-30
November, 2003 EIR Tianjin Zhong Xin Pharmaceutical - EIR, 2003-11-20
September, 2003 FDA 483 Response Abic Ltd. - Form 483R, 2004-10-07
January, 2002 EIR Bracco Imaging S.p.A. - EIR, 2002-01-30
October, 2002 FDA 483 Shanghai Fourth Pharmaceuticals, Ltd. - Form 483, 2002-10-31
November, 2003 FDA 483 Response SHANGHAI ZHONGXI SUNVE PHARMACEUTICAL CO., LTD. - Form 483R, 2003-12-16
October, 2000 FDA 483 Sandoz Incorporated - Form 483, 2000-10-11
November, 2003 FDA 483 Tianjin Zhong Xin Pharmaceutical - Form 483, 2003-11-20
April, 2007 FDA 483 Cody Laboratories, Inc. - Form 483, 2007-04-27
January, 2002 FDA 483 Bracco Imaging S.p.A. - Form 483, 2002-01-30
October, 2002 FDA 483 Sichuan Long March Pharmaceutical Co. Ltd. - Form 483, 2002-10-25
November, 2003 FDA 483 Wuxi Kaili Pharmaceutical Company LTD. - Form 483, 2003-11-07
May, 2001 FDA 483 Johnson Matthey Pharmaceuticals Materials - Form 483, 2001-05-11
November, 2003 FDA 483 Response Wuxi Kaili Pharmaceutical Company LTD. - Form 483R, 2003-12-02
November, 2003 FDA 483 Response Tianjin Zhong Xin Pharmaceutical - Form 483R, 2003-11-28

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more